Tech Company Financing Transactions
HealthTell Funding Round
HealthTell closed a $3.2 million financing round on 5/12/2015. Investors included private investors.
Transaction Overview
Company Name
Announced On
5/12/2015
Transaction Type
Debt
Amount
$3,165,040
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2420 Camino Ramon 125
San Ramon, CA 94583
USA
San Ramon, CA 94583
USA
Phone
Website
Email Address
Overview
The core of HealthTell's diagnostic platform are Antibodies. Our technology produces an Immunosignature: a real time, disease specific health status--all from a single drop of blood.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Colston
Chief Information Officer
Donald Morris
VP - Bus. Development
Isaac Bright
VP - Bus. Development
Glen Ferguson
VP - Finance
Myla Puyat
VP - Operations
David Smith
VP - Product Management
Ted Tarasow
VP - R & D
Kathryn Sykes
VP - Regulatory Affairs
Gary Riordan
Browse more venture capital transactions:
Prev: 5/12/2015: Vadio venture capital transaction
Next: 5/12/2015: Levanto Financial venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs